Patients’ preferences regarding invasive mediastinal nodal staging of resectable lung cancer

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Variability in practice and ongoing debate on optimal invasive mediastinal staging of patients with resectable non-small cell lung cancer (NSCLC) are widely described in the literature. Patients’ preferences on this topic have, however, been underexposed so far. Methods: An internet-based questionnaire was distributed among MEDIASTrial partici-pants (NTR6528, randomization of patients to mediastinoscopy or not in the case of negative endosonography). Literature, expert opinion and patient interviews resulted in five attributes: the risk of a futile lung resection (oncologically futile in case of unforeseen N2 disease), the length of the staging period, resection of the primary tumor, complications of staging procedures and the mediastinoscopy scar. The relative importance (RI) of each attribute was assessed by using adaptive conjoint analysis and hierarchical Bayes estimation. A treatment trade-off was used to examine the acceptable proportion of avoided futile lung resections to cover the burden of confirmatory mediastinoscopy. Results: Ninety-seven patients completed the questionnaire (57%). The length of the staging period was significantly the most important attribute (RI 26.24; 95% CI: 25.05–27.43), followed by the risk of a futile surgical lung resection (RI 23.44; 95% CI: 22.28–24.60) and resection of the primary tumor (RI 22.21; 95% CI: 21.09–23.33). Avoidance of 7% (IQR 1– >14%) futile lung resections would cover the burden of confirmatory mediastinoscopy, with a dichotomy among patients always (39%) or never (38%) willing to undergo confirmatory mediastinoscopy after N2 and N3-negative endosonography. Conclusion: Although a strong dichotomy among patients always or never willing to undergo confirmatory mediastinoscopy was found, the length of the staging period was the most important attribute in invasive mediastinal staging according to patients with resectable NSCLC. Trial Registration: Not applicable.

Cite

CITATION STYLE

APA

Bousema, J. E., Hoeijmakers, F., Dijkgraaf, M. G. W., Annema, J. T., van den Broek, F. J. C., & van den Akker-Van Marle, M. E. (2021). Patients’ preferences regarding invasive mediastinal nodal staging of resectable lung cancer. Patient Preference and Adherence, 15, 2185–2196. https://doi.org/10.2147/PPA.S319790

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free